Company page

Polaryx Therapeutics, Inc.

Polaryx Therapeutics, Inc. (Ticker: PLYX) is a public company based in the United States with a market capitalization of approximately $170.4 million. The company focuses on developing innovative therapeutics to address unmet medical needs. Polaryx is committed to advancing its pipeline and enhancing patient outcomes through its research and development efforts.